Renal Artery Disease

Clinical Trial Finder

This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Aortic Calcification and Central Blood Pressure in Patients With Chronic Kidney Disease

Conditions:   Arterial Calcification;   Kidney Diseases;   Coronary Artery Disease;   Aortic Calcification;   Stroke;   Vascular Diseases;   Vascular Calcification
Intervention:  
Sponsor:   Central Jutland Regional Hospital
Not yet recruiting

Risk Assessment by Cardiovascular Biomarkers in Chronic Dialysis Patients

Condition:   Endstage Renal Disease
Intervention:  
Sponsor:   University Hospital, Basel, Switzerland
Active, not recruiting

Rivaroxaban for the Prevention of Major Cardiovascular Events in Coronary or Peripheral Artery Disease

Condition:   Prevention & Control
Interventions:   Drug: Rivaroxaban (Xarelto, BAY59-7939);   Drug: Aspirin;   Drug: Aspirin placebo;   Drug: Rivaroxaban placebo;   Drug: Pantoprazole
Sponsors:   Bayer;   Population Health Research Institute;   Janssen Research & Development, LLC
Active, not recruiting

e-NOBORI Observational Registry of Nobori DES

Condition:   Coronary Artery Disease
Intervention:  
Sponsor:   Terumo Europe N.V.
Completed

Multi-center Study On the Treatment and Prognosis of Arteriosclerosis Obliterans With Different Caliber Balloon

Condition:   Arteriosclerosis; Extremities
Interventions:   Device: Increased caliber balloon;   Device: matched caliber balloon
Sponsor:   Jun-min Bao
Not yet recruiting

Evaluation of Calcineurin-inhibitor Reduction With Conversion at 2 Months to Everolimus/Reduced Tacrolimus in Renal Transplant Recipients Following Campath® Induction

Condition:   Renal Transplant
Intervention:   Drug: Arm 1 Everolimus/Reduced dose tacrolimus
Sponsors:   University of Toledo Health Science Campus;   Novartis Pharmaceuticals
Active, not recruiting

Acute Kidney Injury Genomics and Biomarkers in TAVR Study

Conditions:   Acute Kidney Injury;   Renal Insufficiency, Chronic;   Heart Failure;   Myocardial Infarction;   Arrhythmias, Cardiac;   Stroke
Intervention:   Procedure: Transcatheter Aortic Valve Replacement
Sponsor:   University of Texas Southwestern Medical Center
Recruiting

A Study Based on Data From German Registries That Looks at Characteristics of People Who Take the Medicine Empagliflozin for Type 2 Diabetes

Condition:   Diabetes Mellitus, Type 2
Intervention:   Drug: Empagliflozin
Sponsor:   Boehringer Ingelheim
Active, not recruiting

XIENCE 28 USA Study

Conditions:   Bleeding Disorder;   Ischemic Stroke;   Hemorrhagic Stroke;   Hematological Diseases;   Thrombocytopenia;   Coagulation Disorder;   Anemia;   Renal Insufficiency;   Coronary Artery Disease
Interventions:   Device: XIENCE;   Drug: DAPT (aspirin and/or P2Y12 receptor inhibitor)
Sponsor:   Abbott Medical Devices
Recruiting

High Resolution Imaging of Retinal Vessels as a Biomarker of Cardiovascular Disease in Patients With Renal Insufficiency - RI

Conditions:   Retinal Imaging;   Cardiovascular Biomarker;   Renal Insufficiency
Intervention:   Diagnostic Test: wall-to-lumen ratio measurement
Sponsors:   Ramsay Générale de Santé;   Dr Céline FAURE
Active, not recruiting

Xanthine Oxidase Inhibition in Renal Transplant Recipients

Condition:   Complications of Renal Transplant
Interventions:   Drug: allopurinol or placebo;   Other: Placebo
Sponsor:   Roberto S Kalil
Terminated

Prospective, Single-arm, Multi Centre Observations Ultimaster Des Registry

Condition:   Coronary Artery Disease
Intervention:  
Sponsor:   Terumo Europe N.V.
Active, not recruiting

Tacrolimus After rATG and Infliximab Induction Immunosuppression (RIMINI)

Condition:   Renal Transplant Rejection
Intervention:   Drug: Antithymocyte Immunoglobulin (Rabbit)
Sponsors:   Prof. Dr. Petra Reinke;   Institut Klinické a Experimentální Medicíny
Recruiting

Study to Evaluate the Efficacy of ASP1128 (MA-0217) in Subjects at Risk for Acute Kidney Injury Following Coronary Artery Bypass Graft (CABG) and/or Valve Surgery

Condition:   Acute Kidney Injury (AKI)
Interventions:   Drug: ASP1128;   Drug: Placebo
Sponsor:   Astellas Pharma Inc
Recruiting

AGNES - Aging Nephropathy Study, a Prospective Observational Cohort of Chronic Kidney Disease in Elderly Patients

Conditions:   Chronic Kidney Diseases;   Elderly;   Mortality;   Renal Replacement Therapy
Intervention:  
Sponsor:   University of Sao Paulo General Hospital
Recruiting

Patient-Derived Stem Cell Therapy for Diabetic Kidney Disease

Conditions:   Diabetic Kidney Disease;   Diabetic Nephropathies;   Diabetes Mellitus, Type 2;   Diabetes Mellitus, Type 1;   Chronic Kidney Disease;   Diabetic Nephropathy Type 2;   Kidney Failure;   Kidney Insufficiency
Interventions:   Biological: Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower Dose;   Biological: Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Higher Dose
Sponsors:   Mayo Clinic;   Regenerative Medicine Minnesota
Recruiting

The Danish Warfarin-Dialysis Study - Safety and Efficacy of Warfarin in Patients With Atrial Fibrillation on Dialysis

Conditions:   Atrial Fibrillation and Flutter;   Stroke;   Major Bleed;   End-stage Renal Disease
Intervention:   Drug: Warfarin
Sponsors:   Nicholas Carlson;   Danish Heart Foundation
Recruiting

Role of Mitochondrial Dysfunction in the Occurrence of Acute Kidney Injury (AKI) in Postoperative Cardiac Surgery

Condition:   Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery Requiring Extracorporeal Circulation
Intervention:   Procedure: Coronary Artery Bypass Graft (CABG)
Sponsor:   University Hospital Center of Martinique
Recruiting

Impact of INsulin Sensitivity on Cardiovascular Risk Markers During 10-20 Years of FOllow up

Conditions:   Diabetes Mellitus;   Hypertension;   Ischemic Heart Disease;   Stroke
Intervention:  
Sponsor:   Oslo University Hospital
Completed

Study on the Registration of Coronary Heart Disease Patients Undergoing PCI

Condition:   Coronary Heart Disease
Intervention:   Drug: antiplatelet agents(Clopidogrel or Ticagrelor)
Sponsor:   The Third Xiangya Hospital of Central South University
Completed

Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment

Condition:   Rheumatologic Disease
Interventions:   Drug: BH4;   Other: Vasculopathy assessment;   Drug: Placebo
Sponsor:   VA Office of Research and Development
Recruiting

Copeptin in Adolescent Participants With Type 1 Diabetes and Early Renal Hemodynamic Function

Conditions:   Diabetes Mellitus, Type 1;   Nephropathy;   Diabetic Nephropathies;   Juvenile Diabetes;   Diabetes Mellitus Complication;   Autoimmune Diabetes;   Type 1 Diabetes Mellitus
Interventions:   Drug: Aminohippurate Sodium Inj 20%;   Drug: Iohexol Inj 300 mg/mL
Sponsor:   University of Colorado Denver School of Medicine Barbara Davis Center
Active, not recruiting

Arterial Stiffness as a Predictor of Response to Renal Sympathetic Denervation

Condition:   Therapy Resistant Arterial Hypertension
Intervention:   Device: Renal sympathetic denervation (RDN)
Sponsor:   University of Leipzig
Recruiting

Hepatitis C Treatment and Atherosclerosis

Conditions:   Chronic Hepatitis C;   Atherosclerosis
Intervention:  
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed

Effects of the Dietary Approaches to Stop Hypertension(DASH) Sodium-restricted Diet in Diastolic Heart Failure

Conditions:   Diastolic Heart Failure;   Hypertensive Heart Disease
Intervention:   Behavioral: DASH/sodium-restricted diet (SRD)
Sponsor:   University of Michigan
Completed

Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study.

Conditions:   Type 2 Diabetes Mellitus;   Diabetic Kidney Disease;   Diabetic Nephropathy;   Renal Hypoxia;   Renoprotection;   SGLT2 Inhibitor;   Ertugliflozin
Intervention:   Drug: Ertugliflozin 15 mg
Sponsor:   VU University Medical Center
Not yet recruiting

SPYRAL HTN-ON MED Study

Conditions:   Hypertension;   Vascular Diseases;   Cardiovascular Diseases
Interventions:   Device: Symplicity Spyral™ multi-electrode renal denervation system;   Procedure: Sham Procedure
Sponsor:   Medtronic Vascular
Recruiting

Bio Impedance-assisted Monitoring of Chronic Hemodialysis Patients

Conditions:   Chronic Kidney Diseases;   Hemodialysis Complication
Intervention:   Device: NICAS
Sponsor:   Assuta Ashdod Hospital
Recruiting

Insulin Resistance and Atherosclerosis in Women With Lupus

Conditions:   Systemic Lupus Erythematosus;   Insulin Resistance;   Atherosclerosis
Intervention:  
Sponsor:   National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Completed

DKK3 for Prognosis and Monitoring of GFR Loss in Heart Failure

Conditions:   Heart Failure;   Chronic Kidney Diseases
Intervention:   Diagnostic Test: No intervention
Sponsor:   University of Giessen
Recruiting

Use of GDF15 as a Biomarker for Early Diagnosis of DM and Monitoring of Progress of Complications in Asians

Conditions:   Diabetes Mellitus, Type 2;   Diabetic Polyneuropathy;   Diabetic Nephropathies
Intervention:  
Sponsor:   Chang Gung Memorial Hospital
Recruiting

Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults With Type 2 Diabetes Mellitus

Conditions:   Obesity;   Overweight;   Diabetes Mellitus, Type 2
Intervention:  
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed

Prevention and Early Detection and Intervention of Post-Coronary Artery Bypass Grafting Surgery (CABG) Acute Kidney Injury (AKI)

Conditions:   Acute Renal Injury;   Preventive Measures
Intervention:   Procedure: Standard of Care plus Nephrology Care
Sponsor:   Mayo Clinic
Completed